Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents

Oncology Reports

Volumn 18, Issue 3, 2007, Pages 593-599

  Jung, Jae Joon ^a   Jeung, Hei Cheul ^a,b   Lee, Jung Ok ^a,b   Kim, Tae Soo ^a,b   Chung, Hyun Cheol ^a   Rha, Sun Young ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Chemotherapy; Colorectal cancer; Predictive gene

Indexed keywords

ANTINEOPLASTIC AGENT; RNA;

ARTICLE; COLORECTAL TUMOR; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, NEOPLASM;

EID: 38449119056     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.3.593     Document Type: Article

References (26)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005. (Pubitemid 40310185)
2. Kune GA, Kune S, Field B, White R, Brough W, Schellenberger R and Watson LF: Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum 33: 938-946, 1990. (Pubitemid 20381642)
3. Rougier P, Van Cutsem E, Bajetta E, Niederle N, Possinger K, Labianca R, Navarro M, Morant R, Bleiberg H, Wils J, Awad L, Herait P and Jacques C: Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352: 1407-1412, 1998. (Pubitemid 28510873)
4. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L and Rougier P: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355: 1041-1047, 2000. (Pubitemid 30162806)
5. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D and Brown PO: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235, 2000. (Pubitemid 30132189)
6. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO and Weinstein JN: A gene expression database for the molecular pharmacology of cancer. Nat Genet 24: 236-244, 2000. (Pubitemid 30132190)
7. Dan S, Tsunoda T, Kitahara O, Yanagawa R, Zembutsu H, Katagiri T, Yamazaki K, Nakamura Y and Yamori T: An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res 62: 1139-1147, 2002. (Pubitemid 34160300)
8. Zembutsu H, Ohnishi Y, Tsunoda T, Furukawa Y, Katagiri T, Ueyama Y, Tamaoki N, Nomura T, Kitahara O, Yanagawa R, Hirata K and Nakamura Y: Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res 62: 518-527, 2002. (Pubitemid 34106426)
9. Staunton JE, Slonim DK, Coller HA, Tamayo P, Angelo MJ, Park J, Scherf U, Lee JK, Reinhold WO, Weinstein JN, Mesirov JP, Lander ES and Golub TR: Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA 98: 10787-10792, 2001. (Pubitemid 32878698)
10. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE and Paull KD: An information-intensive approach to the molecular pharmacology of cancer. Science 275: 343-349, 1997. (Pubitemid 27051604)
11. Wang HY, Malek RL, Kwitek AE, Greene AS, Luu TV, Behbahani B, Frank B, Quackenbush J and Lee NH: Assessing unmodified 70-mer oligonucleotide probe performance on glass-slide microarrays. Genome Biol 4: R5, 2003.
12. Southern E, Mir K and Shchepinov M: Molecular interactions on microarrays. Nat Genet 21: 5-9, 1999. (Pubitemid 29031484)
13. Watson A, Mazumder A, Stewart M and Balasubramanian S: Technology for microarray analysis of gene expression. Curr Opin Biotechnol 9: 609-614, 1998. (Pubitemid 28558491)
14. Zhao X, Nampalli S, Serino AJ and Kumar S: Immobilization of oligodeoxyribonucleotides with multiple anchors to microchips. Nucleic Acids Res 29: 955-959, 2001. (Pubitemid 32162264)
15. Call DR, Chandler DP and Brockman F: Fabrication of DNA microarrays using unmodified oligonucleotide probes. Biotechniques 30: 368-372, 2001.
16. Kane MD, Jatkoe TA, Stumpf CR, Lu J, Thomas JD and Madore SJ: Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. Nucleic Acids Res 28: 4552-4557, 2000.
17. Barczak A, Rodriguez MW, Hanspers K, Koth LL, Tai YC, Bolstad BM, Speed TP and Erle DJ: Spotted long oligonucleotide arrays for human gene expression analysis. Genome Res 13: 1775-1785, 2003. (Pubitemid 36874495)
18. Kim TM, Jeong HJ, Seo MY, Kim SC, Cho G, Park CH, Kim TS, Park KH, Chung HC and Rha SY: Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray. Clin Cancer Res 11: 79-86, 2005. (Pubitemid 40075781)
19. Lin YM, Furukawa Y, Tsunoda T, Yue CT, Yang KC and Nakamura Y: Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21: 4120-4128, 2002. (Pubitemid 34712879)
20. Kang HC, Kim IJ, Park JH, Shin Y, Ku JL, Jung MS, Yoo BC, Kim HK and Park JG: Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res 10: 272-284, 2004. (Pubitemid 38114190)
21. Park JS, Young Yoon S, Kim JM, Yeom YI, Kim YS and Kim NS: Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray. Cancer Lett 214: 19-33, 2004. (Pubitemid 39141195)
22. Hungerford JE, Compton MT, Matter ML, Hoffstrom BG and Otey CA: Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol 135: 1383-1390, 1996.
23. Xu LH, Owens LV, Sturge GC, Yang X, Liu ET, Craven RJ and Cance WG: Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ 7: 413-418, 1996. (Pubitemid 26362085)
24. Ilic D, Almeida EA, Schlaepfer DD, Dazin P, Aizawa S and Damsky CH: Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 143: 547-560, 1998. (Pubitemid 28487870)
25. Gilmore AP and Romer LH: Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 7: 1209-1224, 1996. (Pubitemid 26260738)
26. Burbridge MF, Venot V, Casara PJ, Perron-Sierra F, Hickman JA and Tucker GC: Decrease in survival threshold of quiescent colon carcinoma cells in the presence of a small molecule integrin antagonist. Mol Pharmacol 63: 1281-1288, 2003. (Pubitemid 36627222) and Welfare